ArticleOrphanet journal of rare diseases2024

Clinical investigator perspectives on patient outcomes in children with neuronopathic mucopolysaccharidosis II during intrathecal idursulfase-IT treatment.

Karen S Yee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.